DV

Deer VI & Co. LLC

Concentrated strategy

Total reported value

$2.2M

Reporting period: 2018-09-30 · Number of holdings: 1

Deer VI & Co. LLC disclosed 1 holdings in its latest 13F filing for the period ending 2018-09-30, with total reported value of $2.2M and a quarterly turnover rate of 37.7%.

Personality snowflake

Concentration
100
Portfolio Stability
37.7
Momentum/Contrarian
50
Sector conviction
0
Diversification
2
Sizing Uniformity

Recent moves

  • Unchanged AVEOEUR

    0.0% $709.0K

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1AVEOEURAveo Pharmaceuticals INCStock-Other100.00%

Holding changes this quarter

Position changes disclosed by Deer VI & Co. LLC for the quarter ending 2018-09-30, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction
1AVEOEURAveo Pharmaceuticals INCUnchanged

FAQ

What is Deer VI & Co. LLC and what type of investor is it?
Deer VI & Co. LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2018-09-30), the firm manages a tracked equity portfolio valued at approximately $2.2M, spread across 1 disclosed positions.
What are Deer VI & Co. LLC's largest equity positions?
Based on the latest 13F filing, Deer VI & Co. LLC's top holdings by market value are: 1. Aveo Pharmaceuticals INC (AVEOEUR) — $2.2M (100.0%)
What changes did Deer VI & Co. LLC make in its most recent portfolio filing?
No notable portfolio changes were recorded for Deer VI & Co. LLC in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Deer VI & Co. LLC focus on?
Sector breakdown data is not yet available for Deer VI & Co. LLC. Check back after the next 13F processing cycle.